D. Connell (Dundee, United Kingdom), R. Menendez Villanueva (Valencia, Spain), S. Ott (Bern, Switzerland), O. Sibila (Barcelona, Spain)
Pepsin as a biomarker of reflux in NAR patients
R. Lenham (Kingston Upon Hull, United Kingdom), Q. Wang (Nanjing, China), X. Wang (Nanjing, China), P. Dettmar (Kingston Upon Hull, United Kingdom)
|   |
Vitamin D and Bronchiectasis Severity Index (BSI): A correlation
S. Ferri (Catania, Italy), E. Heffler (Milano, Italy), R. Campisi (Catania, Italy), C. Chessari (Catania, Italy), C. Crimi (Catania, Italy), N. Crimi (Catania, Italy)
| |
Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia.
S. Luquero Bueno (Madrid, Spain), J. Galván-Román (Madrid, Spain), J. Curbelo (Madrid, Spain), M. Ortega-Gómez (Madrid, Spain), Á. Lancho-Sánchez (Madrid, Spain), L. Vega-Piris (Madrid, Spain), M. Gómez (Madrid, Spain), H. De La Fuente (Madrid, Spain), C. Suárez (Madrid, Spain), L. Jiménez-Borreguero (Madrid, Spain), J. Aspa Marco (Madrid, Spain)
| |
Soluble urokinase plasminogen activator receptor (suPAR) for the prediction of ventilator-associated pneumonia (VAP)
P. van Oort (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), P. Povoa (Lisbon, Portugal), P. Ramirez (Valencia, Spain), A. Torres (Madrid, Spain), A. Artigas (Madrid, Spain), M. Schultz (Amsterdam, Netherlands), I. Martin-Loeches (Madrid, Spain)
| |
Serum ferritin as a prognostic marker of pneumonia: a prospective, single center study
J. Kim (Daejeon , Republic of Korea), D. Kim (Gwangju, Republic of Korea), I. Jeong (Daejeon , Republic of Korea), J. Son (Daejeon , Republic of Korea), M. Na (Daejeon , Republic of Korea), S. Kwon (Daejeon , Republic of Korea)
| |
Relationship between Neutrophilic Airway Inflammation and Airway Colonisation in non-Cystic Fibrosis Bronchiectasis
F. Dente (Pisa, Italy), R. Del Cesta (Pisa, Italy), M. Bartoli (Pisa, Italy), M. Bradicich (Pisa, Italy), M. Daniele (Pisa, Italy), M. Roggi (Pisa, Italy), B. Vagaggini (Pisa, Italy), P. Paggiaro (Pisa, Italy)
| |
C-reactive protein (C-RP) in patients with chronic heart failure (CHF) and community-acquired pneumonia (CAP): usefulness to guide antibiotic prescription
A. Bobylev (Smolensk, Russian Federation), S. Rachina (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), S. Rachin (Saint Petersburg, Russian Federation), D. Smirnova (Saint Petersburg, Russian Federation)
| |
LYMPHOPENIA AS PREDICTOR OF LONG TERM MORTALITY IN PATIENTS WITH HOSPITAL ACQUIRED PNEUMONIA
A. Ceccato (Barcelona, Spain), M. Panagiotarakou (Athens, Greece), M. Martin-Fernandez (Valladolid, Spain), R. Almansa Mora (Valladolid, Spain), O. Ranzani (Barcelona, Spain), C. Cilloniz (Barcelona, Spain), G. Li Bassi (Barcelona, Spain), A. Liapikou (Athens, Greece), M. Ferrer (Barcelona, Spain), J. Bermejo- Martin (Valladolid, Spain), A. Torres (Barcelona, Spain)
| |
Serum Albumin-Globulin ratio reversal predicts morbidity in patients hospitalized for Influenza A(H1N1) infection.
K. Ramaraju (Coimbatore, India), A. K Murthy (Coimbatore, India), N. Balasubramaniam (Coimbatore, India), V. Leon (Coimbatore, India)
| |
Usefulness of the measurement of plasma neutrophil gelatinase-associated lipocalin as a biomarker for predicting prognosis in hospitalized patients with pneumonia
S. Kim (Seoul, Republic of Korea), J. Min (Seoul, Republic of Korea), T. Park (Seoul, Republic of Korea), D. Park (Seoul, Republic of Korea), J. Moon (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea), J. Sohn (Seoul, Republic of Korea), H. Yoon (Seoul, Republic of Korea)
| |
The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
E. Wittermans (Nieuwegein, Netherlands), S. Vestjens (Nieuwegein, Netherlands), W. Bos (Nieuwegein, Netherlands), J. Grutters (Nieuwegein, Netherlands), E. Van De Garde (Nieuwegein, Netherlands), B. Vlaminckx (Nieuwegein, Netherlands)
| |
MCC-IMS Spectral Analyses of Volatile Markers for Screening of Clinically Relevant Bacterial Infection
G. Becher (Bernau, Germany), R. Purkhart (Lichtenau, Germany), R. Gerber (Geyer, Germany), W. Schueler (Geyer, Germany), R. Graupner (Geyer, Germany)
| |
The association between phagocytes in Gram-stained sputum and detection of causative organisms
K. Shibutani (Tokyo, Japan), R. Tsugitomi (Tokyo, Japan), R. Imai (Tokyo, Japan), H. Kanemura (Tokyo, Japan), K. Ishii (Tokyo, Japan), K. Okafuji (Tokyo, Japan), A. Kitamura (Tokyo, Japan), E. Hoshino (Tokyo, Japan), H. Ono (Kumamoto, Japan), Y. Tomishima (Tokyo, Japan), T. Jinta (Tokyo, Japan), N. Nishimura (Tokyo, Japan), T. Tamura (Tokyo, Japan)
| |
Thrombotic disorders (blood coagulation test and Padua Prediction Score for risk of lung thrombosis)in hospitalized patients with community-acquired pneumonia (CAP)
M. Krykhtina (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), K. Dyagovets (Dnipro, Ukraine)
| |
Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)?
M. Krykhtina (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine)
| |
Evaluation of clinical and operational outcomes of a Point of Care Test for patients with suspected influenza in an acute medical unit.
A. Jayachandran (Wirral, United Kingdom), M. Ahmad (Wirral, United Kingdom)
| |
The Neutrophil-lymphocyte ratio in patients with community-acquired pneumonia
t. amir (tunis, Tunisia), S. Toujani (tunis, Tunisia), S. Ben Khaled (tunis, Tunisia), A. Slim (tunis, Tunisia), A. Hedhli (tunis, Tunisia), S. Cheikhrouhou (tunis, Tunisia), Y. Ouahchi (tunis, Tunisia), M. Mjid (tunis, Tunisia), S. Merai (tunis, Tunisia)
| |
Is Neutrophil-lymphocyte ratio useful for differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia.
A. Taboubi (Tunis, Tunisia), A. Hedhli (Tunis, Tunisia), S. Toujani (Tunis, Tunisia), S. Ben Khaled (Tunis, Tunisia), A. Slim (Tunis, Tunisia), S. Cheikh Rouhou (Tunis, Tunisia), Y. Ouahchi (Tunis, Tunisia), M. Mjid (Tunis, Tunisia), S. Merai (Tunis, Tunisia)
| |
Procalcitonin has wider applicability in community-acquired pneumonia than other biomarkers
W. Siljan (Drammen, Norway), J. Holter (Drammen, Norway), A. Michelsen (Oslo, Norway), S. Nymo (Oslo, Norway), J. Norseth (Bærum, Norway), E. Husebye (Drammen, Norway), T. Lauritzen (Drammen, Norway), T. Ueland (Oslo, Norway), T. Mollnes (Oslo, Norway), P. Aukrust (Oslo, Norway), L. Heggelund (Drammen, Norway)
| |
IgG3 subclass deficiency as a predictive marker of mortality in patients admitted to ICU
J. Kim (Daejeon, Republic of Korea), D. Kim (Gwangju, Republic of Korea), I. Jeong (Daejeon, Republic of Korea), J. Son (Daejeon, Republic of Korea), M. Na (Daejeon, Republic of Korea), S. Kwon (Daejeon, Republic of Korea)
| |